HGHCX
Price
$21.99
Change
+$0.24 (+1.10%)
Updated
Jul 16 closing price
Net Assets
765.89M
JFNIX
Price
$66.97
Change
+$0.84 (+1.27%)
Updated
Jul 16 closing price
Net Assets
4.4B
Interact to see
Advertisement

HGHCX vs JFNIX

Header iconHGHCX vs JFNIX Comparison
Open Charts HGHCX vs JFNIXBanner chart's image
Hartford Healthcare C
Price$21.99
Change+$0.24 (+1.10%)
VolumeN/A
Net Assets765.89M
Janus Henderson Global Life Sciences I
Price$66.97
Change+$0.84 (+1.27%)
VolumeN/A
Net Assets4.4B
HGHCX vs JFNIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HGHCX vs. JFNIX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHCX is a Hold and JFNIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.4B vs. HGHCX (766M). JFNIX pays higher dividends than HGHCX: JFNIX (0.41) vs HGHCX (0.00). HGHCX was incepted earlier than JFNIX: HGHCX (25 years) vs JFNIX (16 years). HGHCX (2.07) is less costly to investors than JFNIX (0.77). HGHCX is a more actively managed with annual turnover of: 40.00 vs. JFNIX (35.00). HGHCX has a lower initial minimum investment than JFNIX: HGHCX (2000) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -17.51 vs. HGHCX (-23.47). JFNIX return over 5 years is better than : 1.36 vs. HGHCX (-32.09).
HGHCXJFNIXHGHCX / JFNIX
Total Expense Ratio2.070.77269%
Annual Report Gross Expense Ratio2.070.77269%
Fund Existence25 years16 years-
Gain YTD-7.249-2.779261%
Front LoadN/AN/A-
Min. Initial Investment2000250080%
Min. Initial Investment IRAN/AN/A-
Net Assets766M4.4B17%
Annual Yield % from dividends0.000.41-
Returns for 1 year-23.47-17.51134%
Returns for 3 years-10.687.86-136%
Returns for 5 years-32.091.36-2,358%
Returns for 10 years-42.254.97-849%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FINSX48.28N/A
N/A
Fidelity Advisor New Insights I
TDEIX32.14N/A
N/A
Transamerica US Growth I
HSUCX32.69N/A
N/A
Rational Dynamic Brands C
AVUNX19.46N/A
N/A
Avantis® U.S. Equity G
PRCFX28.29N/A
N/A
T. Rowe Price Cap Apprec And Inc